Ulrike Protzer
#88,614
Most Influential Person Now
German virologist
Ulrike Protzer's AcademicInfluence.com Rankings
Ulrike Protzerbiology Degrees
Biology
#4203
World Rank
#6301
Historical Rank
Virology
#108
World Rank
#111
Historical Rank
Download Badge
Biology
Ulrike Protzer's Degrees
- PhD Virology Ludwig Maximilian University of Munich
- Doctorate Medicine Ludwig Maximilian University of Munich
Why Is Ulrike Protzer Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ulrike Protzer is a German virologist who has been a professor at the Chair of Virology at the Technical University of Munich since 2007. Her primary field of study is virus-host interactions of the hepatitis B virus and her work is focused on developing new therapeutic approaches for the treatment of chronic hepatitis B infection and related secondary diseases. Since the beginning of the COVID-19 pandemic, the novel virus SARS-CoV-2 has also been one of her research areas, and she has been a prominent voice in German media on this topic.
Ulrike Protzer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA (2014) (765)
- Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. (2014) (475)
- Living in the liver: hepatic infections (2012) (462)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. (2011) (373)
- Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series (2020) (368)
- Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV (2020) (354)
- Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection (2009) (334)
- Viral hepatitis and liver cancer (2017) (254)
- Immunosurveillance of the Liver by Intravascular Effector CD8+ T Cells (2015) (240)
- Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. (2016) (230)
- Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus (2009) (195)
- Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection (2013) (193)
- [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. (2018) (185)
- Functional classification of memory CD8+ T cells by CX3CR1 expression (2015) (185)
- [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. (2011) (181)
- Control of hepatitis B virus at the level of transcription (2010) (179)
- T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. (2013) (178)
- HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. (1997) (169)
- Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure. (2016) (155)
- Transfer of Hepatitis B Virus Genome by Adenovirus Vectors into Cultured Cells and Mice: Crossing the Species Barrier (2001) (146)
- Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern (2022) (145)
- Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells (2011) (142)
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells (2013) (141)
- Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. (2007) (137)
- T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. (2008) (135)
- Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection (2016) (127)
- Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. (2018) (124)
- Toll‐like receptor 2–mediated innate immune response in human nonparenchymal liver cells toward adeno‐associated viral vectors (2012) (124)
- Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. (2017) (123)
- Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. (1993) (121)
- Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection. (2019) (119)
- Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain (2012) (118)
- Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice (2012) (114)
- Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. (1999) (112)
- Hepatic Bax Inhibitor-1 Inhibits IRE1α and Protects from Obesity-associated Insulin Resistance and Glucose Intolerance* (2009) (110)
- The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets (2015) (109)
- Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection (2006) (106)
- Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. (2007) (99)
- Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. (2003) (98)
- Regulation of endotoxin‐induced IL‐6 production in liver sinusoidal endothelial cells and Kupffer cells by IL‐10 (1997) (95)
- Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. (2017) (93)
- PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation (2017) (93)
- Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription (2013) (92)
- Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes. (2013) (92)
- A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children (2020) (91)
- Inhibition of Cellular Proteasome Activities Enhances Hepadnavirus Replication in an HBX-Dependent Manner (2004) (89)
- A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice. (2013) (88)
- Control of Hepatitis B Virus by Cytokines (2017) (87)
- Interleukin‐10 expression is autoregulated at the transcriptional level in human and murine kupffer cells (1998) (86)
- Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 (2021) (86)
- Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (2021) (85)
- Revisiting Hepatitis B Virus: Challenges of Curative Therapies (2019) (83)
- T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. (2015) (81)
- Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. (2012) (77)
- A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses. (2012) (75)
- The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data (2018) (73)
- 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. (2011) (70)
- [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]. (2007) (68)
- HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans (2014) (68)
- Therapeutic vaccination for chronic hepatitis B. (2017) (67)
- Programmable icosahedral shell system for virus trapping (2021) (63)
- Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting (2021) (62)
- Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein (2015) (60)
- TNF-induced target cell killing by CTL activated through cross-presentation. (2012) (60)
- Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 (2020) (59)
- Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. (2015) (58)
- Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort (2020) (57)
- Immune Control of Hepatitis B Virus (2011) (57)
- Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. (1998) (57)
- Induction of Antiviral Cytidine Deaminases Does Not Explain the Inhibition of Hepatitis B Virus Replication by Interferons (2007) (56)
- Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination. (2018) (54)
- Apoptosis of Hepatitis B Virus-Infected Hepatocytes Prevents Release of Infectious Virus (2010) (54)
- Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques (2017) (54)
- A concerted action of HNF4α and HNF1α links hepatitis B virus replication to hepatocyte differentiation (2008) (53)
- Overnight Resting of PBMC Changes Functional Signatures of Antigen Specific T- Cell Responses: Impact for Immune Monitoring within Clinical Trials (2013) (53)
- Direct Effects of Hepatitis B Virus-Encoded Proteins and Chronic Infection in Liver Cancer Development (2013) (51)
- Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. (2008) (49)
- T cell receptor grafting allows virological control of Hepatitis B virus infection. (2019) (48)
- Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice. (2016) (47)
- One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors (2018) (46)
- Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment (2012) (41)
- Liver-specific expression of interferon γ following adenoviral gene transfer controls hepatitis B virus replication in mice (2005) (41)
- Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion AWMF-Register-Nr.: 021/011 Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection - (2011) (41)
- Modified Vaccinia Virus Ankara-Infected Dendritic Cells Present CD4+ T-Cell Epitopes by Endogenous Major Histocompatibility Complex Class II Presentation Pathways (2014) (40)
- Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-titer HBV Carrier Mice. (2020) (40)
- Single cell polarity in liquid phase facilitates tumour metastasis (2018) (38)
- Bioluminescence imaging allows measuring CD8 T cell function in the liver (2010) (38)
- Sequential control of hepatitis B virus in a mouse model of acute, self‐resolving hepatitis B (2011) (37)
- Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model. (2019) (35)
- Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines (2018) (34)
- Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC? (2017) (34)
- New pharmacological strategies to fight enveloped viruses (2014) (34)
- The German guideline for the management of hepatitis B virus infection: short version * (2008) (34)
- N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection (2017) (32)
- Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern (2021) (32)
- Outbreak of COVID-19 in Germany Resulting from a Single Travel-Associated Primary Case (2020) (32)
- Response to Comment on “Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA” (2014) (31)
- Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level (2019) (30)
- Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents (2022) (30)
- Design of therapeutic vaccines: hepatitis B as an example (2012) (29)
- Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2020) (29)
- Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation (2015) (29)
- Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients. (2012) (29)
- Immune Escape by Hepatitis B Viruses (2004) (28)
- Serious outbreak of human metapneumovirus in patients with hematologic malignancies (2016) (28)
- Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19 (2021) (28)
- Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C (2005) (27)
- Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. (2005) (27)
- Analyses of HBV cccDNA Quantification and Modification. (2017) (27)
- [Follow-up of Crohn's disease: can hydro-MRI replace fractionated gastrointestinal passage examination?]. (1997) (26)
- COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma (2021) (26)
- Endotoxin Stimulates Liver Macrophages To Release Mediators That Inhibit an Early Step in Hepadnavirus Replication (2000) (26)
- Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion (2020) (25)
- Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. (2004) (25)
- New norovirus classified as a recombinant GII.g/GII.1 causes an extended foodborne outbreak at a university hospital in Munich. (2013) (25)
- Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients (2021) (25)
- Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro (2015) (24)
- [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association]. (1996) (23)
- Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection (2019) (23)
- S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11) (2021) (23)
- Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages (2022) (23)
- Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. (2016) (23)
- Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication (2017) (23)
- IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection (2017) (23)
- Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro (2017) (23)
- Oncogenic potential of hepatitis B virus encoded proteins. (2015) (22)
- Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use (2017) (22)
- Blocking sense‐strand activity improves potency, safety and specificity of anti‐hepatitis B virus short hairpin RNA (2016) (22)
- Long-Term Suppression of Hepatitis B Virus Replication by Short Hairpin RNA Expression Using the Scaffold/Matrix Attachment Region-Based Replicating Vector System pEPI-1 (2008) (22)
- Novel viral and host targets to cure hepatitis B. (2017) (21)
- A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection (2019) (21)
- Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention. (2019) (21)
- Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model (2010) (21)
- Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma. (2009) (19)
- A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis (2019) (19)
- Elevated Epstein–Barr virus loads and lower antibody titers in competitive athletes (2010) (19)
- The hepatitis B epidemic and the urgent need for cure preparedness (2018) (19)
- Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon‐α therapy (2000) (19)
- Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells (2018) (18)
- Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy (2020) (18)
- Hepatitis B virus infection enhances susceptibility toward adeno‐associated viral vector transduction in vitro and in vivo (2014) (18)
- Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20 (2021) (18)
- Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection (2017) (18)
- A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook (2022) (17)
- Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring (2016) (17)
- Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter (2021) (17)
- MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays (2010) (17)
- Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus infected hepatocytes. (2019) (17)
- Mouse models for therapeutic vaccination against hepatitis B virus (2015) (16)
- Pre‐core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation (1996) (16)
- Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin (2014) (16)
- Über Alkalimanganate(III) bis (V) (1969) (16)
- Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors. (2016) (16)
- Hepatitis B virus‐specific T‐cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment (2014) (16)
- PASylated interferon &agr; efficiently suppresses hepatitis B virus and induces anti‐HBs seroconversion in HBV‐transgenic mice (2019) (16)
- Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19 (2021) (15)
- Viral hepatitis: The bumpy road to animal models for HBV infection (2017) (15)
- Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion (2018) (15)
- Herpes simplex virus in bronchoalveolar lavage fluid of medical intensive care unit patients: Association with lung injury and outcome. (2016) (15)
- "To Be or Not to Be": Immune Tolerance in Chronic Hepatitis B. (2016) (15)
- Neighbor of punc E11, a novel oncofetal marker for hepatocellular carcinoma (2011) (15)
- Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases (2016) (14)
- Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing (2021) (14)
- Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP. (2021) (14)
- Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection (2014) (14)
- Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp. (2012) (14)
- Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer (2020) (14)
- Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages. (2002) (14)
- LINE(1)s of evidence in HBV-driven liver cancer. (2014) (14)
- Schistosome infection aggravates HCV‐related liver disease and induces changes in the regulatory T‐cell phenotype (2015) (13)
- Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein (2021) (13)
- Antiviral gene therapy. (2009) (13)
- Detailed stratified GWAS analysis for severe COVID-19 in four European populations (2022) (13)
- New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (2021) (13)
- Hypoxia‐Inducible Factor 1 Alpha–Mediated RelB/APOBEC3B Down‐regulation Allows Hepatitis B Virus Persistence (2021) (12)
- A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control (2020) (12)
- Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycle (2020) (12)
- Adoptive T‐cell therapy as a therapeutic option for chronic hepatitis B (2007) (12)
- Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection (2021) (12)
- Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg) (2017) (11)
- Innate immune recognition and modulation in hepatitis D virus infection (2020) (11)
- Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA) (2021) (11)
- HDVdb: A Comprehensive Hepatitis D Virus Database (2020) (11)
- Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection. (2021) (11)
- Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models (2020) (10)
- Isolated norovirus GII.7 strain within an extended GII.4 outbreak (2010) (10)
- Hepatitis: Epigenetic control of HBV by HBx protein—releasing the break? (2015) (10)
- [97] T CELLS REDIRECTED AGAINST HEPATITIS B VIRUS SURFACE PROTEINS ELIMINATE INFECTED HEPATOCYTES (2007) (10)
- A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope (2020) (10)
- Frontiers in Clinical Drug Research-Anti Infectives (2017) (10)
- Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle. (2018) (10)
- T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice. (2021) (10)
- Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study (2015) (9)
- Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients (2022) (9)
- Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany (2022) (9)
- Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors. (2021) (9)
- Entecavir Allows an Unexpectedly High Residual Replication of HBV Mutants Resistant to Lamivudine (2015) (9)
- Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected Hepatocytes (2018) (9)
- Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data (2020) (9)
- Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection. (2019) (9)
- Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting (2021) (9)
- Efficient inhibition of SARS-CoV-2 strains by a novel ACE2-IgG4-Fc fusion protein with a stabilized hinge region (2020) (8)
- CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients (2021) (8)
- Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B (2021) (8)
- Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p (2021) (8)
- A PCR assay to quantify patterns of HBV transcription (2019) (8)
- Rare pre‐core stop‐codon mutant nt. 1897 predominates over wide‐spread mutant nt. 1896 in an unusual course of chronic hepatitis B (1996) (8)
- IFN-alpha-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection (2016) (8)
- [German guidelines on diagnosis and therapy of hepatitis B]. (2007) (8)
- Hepatitis B Core Antibody: Role in Clinical Practice in 2020 (2020) (8)
- Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany (2020) (8)
- Towards curative therapy of chronic viral hepatitis (2019) (7)
- Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work! (2020) (7)
- Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? (2013) (7)
- Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (7)
- Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 (2022) (6)
- Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytes. (2020) (6)
- COVID-19-associated Large Vessel Stroke in a 28-year-old Patient (2021) (6)
- Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B? (2010) (6)
- Zur Bildung von Additionsverbindungen zwischen SiCl4HP(C2H5)2 und HSiCl3HP(C2H5)2 (1968) (6)
- Chimeric antigen receptor ( CAR )-engineered T cells redirected against hepatitis C virus ( HCV ) E 2 glycoprotein (2015) (6)
- Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting (2020) (6)
- Hepatitis B Virus X Protein: A Key Regulator of the Virus Life Cycle (2012) (5)
- Correction to ‘Viral hepatitis and liver cancer’ (2017) (5)
- Preclinical study of a combinatorial RNAi/vaccination therapy as a potential cure for chronic hepatitis B (2017) (5)
- Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection (2021) (5)
- Concentration of Na+-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virus (2021) (5)
- Extracellular vesicles derived from Hepatitis-D Virus infected cells induce a proinflammatory cytokine response in human peripheral blood mononuclear cells and macrophages (2020) (5)
- Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic. (2012) (5)
- Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with Dendritic Cells pulsed by HBVsvp (2011) (5)
- PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B (2022) (5)
- Construction of recombinant adenoviruses that produce infectious hepatitis B virus. (2004) (5)
- Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies (2021) (5)
- Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders (2021) (5)
- Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany (2020) (5)
- Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesicles (2020) (5)
- Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems (2019) (4)
- Synchronized infection identifies early rate-limiting steps in the hepatitis B virus life cycle (2020) (4)
- Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design (2021) (4)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight (2020) (4)
- Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity (2022) (4)
- Combinatorial RNAi/vaccination therapy for chronic hepatitis B achieves long-term functional cure in preclinical mouse model (2018) (4)
- Type III interferons induce cccDNA degradation similar to type I interferons in HBV-infected HepaRG cells (2015) (4)
- P169 INTERFERON INDUCIBLE SECRETED FACTORS RESTRICT HBV BINDING (2014) (4)
- Strategie einer universitären Notaufnahme für das COVID-19-Management im Rahmen einer beginnenden Epidemie (2020) (3)
- Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells (2022) (3)
- SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic (2020) (3)
- Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism (2021) (3)
- Presence of Replicating Virus in Recombinant Hepadnavirus Stocks Results from Recombination and Can Be Eliminated by the Use of a Packaging Cell Line (2003) (3)
- Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication (2006) (3)
- Risk Reduction of Cervical Cancer Through HPV Screening and Vaccination—Assumptions and Reality (2014) (3)
- [Erratum to: Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example]. (2020) (3)
- Ethanol attenuates presentation of cytotoxic T-lymphocyte epitopes on hepatocytes of HBV-infected humanized mice. (2021) (3)
- Hepatitis B, C and D virus prevalence in children and adults in Mbeya Region, Tanzania: results from a cohort study 2002 - 2009 (2021) (3)
- Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma (2022) (3)
- [Specific degradation of nuclear hepatitis B virus covalently closed circular DNA]. (2014) (3)
- T cells grafted with HBV-specific T-cell receptors of high functional avidity achieve functional cure of HBV infection in humanized mice (2018) (3)
- Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing (2022) (3)
- Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications (2021) (3)
- Fully Automated Chemiluminescence Microarray Analysis Platform for Rapid and Multiplexed SARS-CoV-2 Serodiagnostics. (2022) (2)
- Estimation of the genotype distribution within global chronic hepatitis B virus infections (2019) (2)
- Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting (2021) (2)
- Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity (2022) (2)
- 59 LYMPHOTOXIN beta RECEPTOR ACTIVATION LEADS TO DEGRADATION OF HBV cccDNA FROM INFECTED HEPATOCYTES (2013) (2)
- Recruitment of highly functional SARS-CoV-2-specific CD8+ T cell receptors mediating cytotoxicity of virus-infected target cells in non-severe COVID-19 (2021) (2)
- Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane (2020) (2)
- Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im Winter 2021/2022 (2021) (2)
- A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry (2021) (2)
- Fetomaternal immune crosstalk modifies T cell priming through sustained changes to DC function. (2021) (2)
- Two-Year Follow-Up on Chemosensory Dysfunction and Adaptive Immune Response after Infection with SARS-CoV-2 in a Cohort of 44 Healthcare Workers (2022) (2)
- Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors (2021) (2)
- RNA Interference Mediated Suppression of HBV Transcripts Restores HBV-Specific Immunity and Enhances the Efficacy of Therapeutic Vaccination (2016) (2)
- [Long-term damage to duodenal mucosa in malabsorption syndrome as a sequela of Giardia lamblia infection]. (1995) (2)
- Quantitation of norovirus-specific IgG before and after infection in immunocompromised patients (2019) (2)
- Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
- 8 Hepatitis viruses (2012) (1)
- Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. (2022) (1)
- Visualizing HEV infection in human liver tissue. (2017) (1)
- Prolonged norovirus infections correlate to quasispecies evolution resulting in structural changes of surface-exposed epitopes (2021) (1)
- Correction to: Hepatitis B Core Antibody: Role in Clinical Practice in 2020 (2020) (1)
- Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV (2017) (1)
- Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing (2021) (1)
- Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure (2023) (1)
- 41 IL6, IL6-INDUCED MIRNAS AND HNF1A/HNF4A AND THE EPIGENETIC CONTROL OF CCCDNA TRANSCRIPTION (2012) (1)
- Transfer of HBV Genomes into Mice (2005) (1)
- Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay (2022) (1)
- Enteropathische Spondarthritiden bei chronisch entzündlichen Darmerkrankungen: Prävalenz, Befallsmuster und HLA-Assoziation (1997) (1)
- Bispecific antibody constructs mediate immunotherapeutic retargeting of effector cells towards HBV infected target cells (2015) (1)
- Hypoxic gene expression in chronic hepatitis B infected patients is not observed in state-of-art in vitro and mouse infection models (2020) (1)
- Anti-Infective Polypeptides for Combating Bacterial and Viral Infections (2014) (1)
- Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages (2022) (1)
- [Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example]. (2020) (1)
- [Antiviral drugs : Potent agents, promising therapies for COVID‑19 and therapeutic limitations]. (2022) (1)
- Hepatitis B virus: lessons learned from the virus life cycle. (2008) (1)
- 1204 THE PEPSI PROJECT: HCV RESISTANCE SCREENING AND PREDICTION OF PI-CONTAINING THERAPY OUTCOME (2013) (1)
- 74 NOVEL PEPTIDE-BASED MICROBIOCIDES INHIBITING HEPATITIS B VIRUS ENTRY BY PREVENTING VIRUS INTERACTION WITH THE CELL SURFACE (2011) (1)
- Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant (2014) (1)
- Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants (2022) (1)
- O48 VISUALIZATION OF HCV HOST CELL TARGETING IN EX VIVO PERFUSED HUMAN LIVER (2014) (1)
- Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients (2021) (1)
- 752 THERAPEUTIC VACCINATION FOR CHRONIC HEPATITIS B (CHB) USING HETEROLOGOUS PROTEIN PRIME/VECTOR BOOST VACCINATION SCHEME (2013) (1)
- T-Cell Receptor Grafting allows Control of Hepatitis B Virus Infection (2019) (1)
- Reopening the Bavarian State Opera Safely: Hygiene Strategies and Incidence of COVID-19 in Artistic Staff During Theater Season 2020/2021 (2021) (1)
- Viral integration profiles in the plasma cell-free DNA from patients with HBV infection well represent tumor clone compositions during HCC development (2018) (1)
- Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA (2022) (1)
- Novel rtM204 Mutations in HBV Polymerase Confer Reduced Susceptibility to Adefovir and Tenofovir (2017) (1)
- Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment (2012) (1)
- 92 ENDOTHELIAL CELL CROSS-PRESENTATION INITIATES TNFA-DEPENDENT CD8 T CELL IMMUNITY AGAINST VIRUS-INFECTED HEPATOCYTES (2010) (0)
- Bi- and Trispecific Antibody Constructs Mediate Specific T-Cell Retargeting Towards and Elimination of HBV-Positive Hepatocytes and Tumor Cells (2016) (0)
- T cells redirected by a chimeric antigen receptor recognizing HBsAg efficiently control HBV in vivo in transgenic mice (2014) (0)
- Endothelial cell cross-presentation initiates TNFα-dependent CD8 T cell immunity against virus-infected hepatocytes (2010) (0)
- Statins suppress hepatitis B virus replication and reduce hepatoma cell viability by interfering with Rho-GTPases (2018) (0)
- CD8 T cell mediated immune response against cross-presenting liver sinusoidal endothelial cells leads to hepatitis (2009) (0)
- 346 Enhanced anti-tumor activity of HBsAg specific TCR-T (SCG101) in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) by preventing T cell exhaustion through PD-1/PD-L1 axis blockade (2022) (0)
- SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19 (2023) (0)
- 108 HEPATITIS B VIRUS X PROTEIN IS REQUIRED FOR PRODUCTIVE INFECTION OF HUMAN HEPATOCYTES (2010) (0)
- Hepatitis B virus escapes non-canonical CTL effector function (2018) (0)
- Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV (2019) (0)
- Hepatitis B Virus Infection of Human Stem Cells-Derived Hepatocyte-Like Cells (2016) (0)
- Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patients (2023) (0)
- P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes (2014) (0)
- Abstract A09: GPR64-specific CAR-transgenic T cells selectively kill Ewing sarcoma in vivo (2018) (0)
- miR-125b regulates the Lin-28/IGF-II axis during hepatocellular carcinogenesis (2013) (0)
- HIV-1 infection impairs frequency and functionality of HBV-specific CD4 T cells in patients with chronic hepatitis B (2014) (0)
- Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins (2022) (0)
- Dysfunctional liver-resident CXCR6+ CD8 T cells during persistent viral liver infection (2022) (0)
- HDVdb: Hepatitis D virus database (2019) (0)
- Reply to the Letter of Charre et al. “Mis-Genotyping of Some Hepatitis D Virus Genotype 2 and 5 Sequences Using HDVdb” (2020) (0)
- Antiviral and antitumor activity of SCG101, an autologous HBV-specific T cell receptor engineered T cell (TCR-T) therapy in HBV-related advanced hepatocellular carcinoma (HCC) patients after receiving ≥2 prior lines of systemic therapies (2022) (0)
- 699. shRNA Sense Strand Neutralization Reduces Off-Targeting, Ameliorates Toxicity and Enhances Efficacy of RNAi-Based HBV Gene Therapy (2015) (0)
- Oxygenation and miR138-5 p act as rheostats in APOBEC3B-mediated Hepatitis B Virus control (2020) (0)
- Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity (2021) (0)
- HEV1 O‐15: Transcriptome analysis of host responses against HEV pORF3 (2015) (0)
- Hepatitis B virus-specific T cell receptors with high functional redirect T cells to eliminate HBV (2018) (0)
- Functional Characterization of HBV-Specific T Cell Receptors for Redirection of T Cells Against HBV-Infected Hepatocytes (2016) (0)
- Innate Immunity and Disorders of the Liver (2014) (0)
- Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents (2022) (0)
- O101 INTERFERON γ AND TUMOR NECROSIS FACTOR a TREATMENT INDUCE COVALENTLY CLOSED CIRCULAR DNA DEGRADATION IN HEPATITIS B VIRUS INFECTED HEPATOCYTES (2014) (0)
- IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection (2017) (0)
- Antigen presentation by macrophages is not inhibited by human cytomegalovirus and infected cells stimulate proliferation and activation of autologous T cells (2015) (0)
- A thermostable therapeutic vaccine is able to break immune tolerance in a mouse model of chronic hepatitis B (2022) (0)
- Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance (2022) (0)
- Adenoviral transfer of HBV genomes allows to MIMIC adult and neonatal HBV infection (2003) (0)
- Sustainable strategies against the COVID-19 pandemic in Germany in winter 2021/2022 | Strategies to contain the COVID-19 pandemic (0)
- Interaction of Hepatitis B virus (HBV) with p53 family-induced apoptosis signaling pathways is involved in viral clearance (2009) (0)
- Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring (2016) (0)
- Targeted therapy in cholestatic and autoimmune liver diseases (2013) (0)
- Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies. (2022) (0)
- Unravelling the role of hepatocytes in hepatitis B virus specific immunotolerance (2022) (0)
- P0632 : Bispecific antibody constructs mediate specific retargeting towards and elimination of HBV-positive hepatocytes and tumor cells (2015) (0)
- Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice (2023) (0)
- RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers (2023) (0)
- Single cell polarity in liquid phase facilitates tumour metastasis (2018) (0)
- Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models (2020) (0)
- Adsorption and Inactivation of SARS-CoV-2 on the Surface of Anatase TiO2(101). (2023) (0)
- Solving the cold chain problem - development of a heat-stable therapeutic vaccine to combat chronic hepatitis B (2020) (0)
- 867 THE ROLE OF MICRORNA-125B REPRESSION IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMA (2010) (0)
- Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
- Mitosis of Hepatitis B virus-infected cells results in uninfected daughter cells (2022) (0)
- Foodborne Outbreak by a Recombinant Norovirus GIIg/1 Strain in a University Hospital in Munich (2012) (0)
- O.110 Role of cellular differentiation for the efficiency of HBV replication (2006) (0)
- 115 CD8 T CELL-MEDIATED IMMUNE RESPONSES AGAINST CROSS-PRESENTING LIVER SINUSOIDAL ENDOTHELIAL CELLS LEADS TO HEPATITIS (2009) (0)
- The role of the CD95 system in the elimination of Hepatitis B Virus-infected hepatocytes: implications for viral clearance (2013) (0)
- ResearchNef-specific CD 45 RA + CD 8 + T cells secreting MIP-1 β but not IFN-γ are associated with nonprogressive HIV-1 infection (2015) (0)
- Analysis and phenotyping of Hepatitis B virus-encoded proteins in the development of liver cancer (2013) (0)
- HBs-directed T cell engager antibodies foster efficient recruitment of T cells and lead to strong reduction of HBV infection in livers of humanized mice (2023) (0)
- Add-on of pegylated interferon alpha–2a (PEG-IFN) triggers antigen-independent TNF-alpha production by CD4+ T cells in patients with pretreated chronic hepatitis B (2012) (0)
- Immunocompromised patients with therapy-refractory chronic skin diseases show reactivation of latent EBV and CMV infection. (2021) (0)
- Generation and functional analsis of spacer modified HBV-specific chimeric antigen receptors that harbor a Fab fragment as binding domain (2022) (0)
- Phenotypic characterization of circulating monofunctional TNF-alpha+ CD4 T cells in patients with acute and chronic hepatitis B (2013) (0)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: 3 approved with reservations] (2021) (0)
- PO-187 Liquid-phase polarity facilitates attachment, adhesion and metastasis of tumour cells (2018) (0)
- AAV capsids induce innate immune responses in human non-parenchymal liver cells (2011) (0)
- Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+tumour cells in vivo (2016) (0)
- Evaluation of strategies to increase safety of adoptively transferred HBV-specific T cells (2019) (0)
- FRI-155-Characterization of a library of CD4+ T cells for T-cell therapy of HBV infection (2019) (0)
- MOESM1 of Validation of an IFNÎł/IL2 FluoroSpot assay for clinical trial monitoring (2016) (0)
- Quantitation of norovirus-specific IgG before and after infection in immunocompromised patients (2019) (0)
- OC-9 IL6, IL6-induced miRNAs and HNF1α/HNF4α in the epigenetic control of cccDNA transcription (2012) (0)
- Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques (2017) (0)
- KAPITEL B8 – Leber (2008) (0)
- Abstract 3764: Targeting GPR64 in pediatric sarcomas with CAR transgenic T cells (2017) (0)
- PS-028-Viral escape contributes to the failure of hepatitis D virus-specific CD8+ T-cells and drives evolution of HDV (2019) (0)
- SAT-184-Approximation of the genotype distribution within global chronic hepatitis B virus infections (2019) (0)
- Structural studies of hepatitis C virus non-structural protein-5b of genotype 4a (2020) (0)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: awaiting peer review] (2020) (0)
- Characterization of MHC class II-restricted T-cell receptors for T-cell therapy of HBV infection (2019) (0)
- Enhancing safety and efficacy of RNAi-based gene therapy for the treatment of chronic hepatitis B (2014) (0)
- Regulated Expression of IFN gamma in the Liver Allows Analysis of the Effect on HBV Replication in Mice (2004) (0)
- Mouse models for therapeutic vaccination against hepatitis B virus (2014) (0)
- Effect of liver-specific IFN-g expression in chronic hepatitis C virus infection (2003) (0)
- Hemmung der Makrophagen abhängigen Wachstumsfaktoren durch Sorafenib (2012) (0)
- P0563 : RNAi-based gene therapy for chronic hepatitis B: Evaluation in a murine model (2015) (0)
- COVIX—An Index Allowing for the Assessment of the Pandemic Situation Based on Infections and Hospitalisation Data (2023) (0)
- Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis (2022) (0)
- Multicistronic DNA-based therapeutic vaccine as a promising candidate to treat chronic hepatitis B virus (HBV) infection (2020) (0)
- P180: Molecular signatures reveal a novel HLA‐B*15‐restricted CD8 T cell epitope on the large hepatitis delta antigen (2015) (0)
- In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity (2021) (0)
- Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients (2023) (0)
- Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection (2021) (0)
- Multi kinase inhibitor Sorafenib modulates cytokine secretion by HCC and liver tissue (2011) (0)
- 128 Cure of HBV infection: can APOBEC3 deaminases mediate it? (2014) (0)
- Strategietreffen: Virushepatitis in Deutschland eliminieren – Was ist zu tun? (2023) (0)
- Active replication of hepatitis B virus (HBV) starts after birth (2007) (0)
- Die Interaktion von Hepatitis B Virus (HBV) mit TAp73 und ΔNp73 ist ein entscheidender Faktor für die Viruselimination (2008) (0)
- Das CD95 Apoptose-System spielt eine wichtige Rolle in der Virus-Elimination bei Hepatitis B Infektion (2004) (0)
- Molekulare Grundlage der Hepatitis B Virus (HBV) -induzierten Apoptose: Aktivierung von Todesrezeptoren und Mitochondrien und Kooperation mit Wildtyp p53 (2015) (0)
- Ein Mausmodell der akuten Hepatitis B: virologische, immunologische und histopathologische Charakterisierung (2005) (0)
- [419] ANTIVIRAL ACTIVITY AND HEPATOPROTECTION BY HEME OXYGENASE-1 IN MODELS OF HUMAN HEPATITIS B INFECTION (2007) (0)
- Erratum zu: Strategie einer universitären Notaufnahme für das COVID-19-Management im Rahmen einer beginnenden Epidemie (2020) (0)
- Klonierung AFP-spezifischer HLA.A2 allo-restringierter cytotoxischer T-Zellen aus dem naiven T Zell Repertoire (2012) (0)
- Ein intakter CD95-Apoptosesignalweg ist notwendig für eine effektive Elimination des Hepatitis B Virus (HBV) (2004) (0)
- Sorafenib modulates tumor-associated macrophages and perpetuates natural killer cell functions (2013) (0)
- Der Differenzierungsgrad von Hepatozyten: Einfluss auf die Hepatitis B Virus Infektion (2005) (0)
- Innovative SARS-CoV-2-Diagnostik via Telemedizin: Auswirkungen auf die Pandemie aus Sicht eines großen Industrieunternehmens (2021) (0)
- OMEPRAZOL : PHARMAKOLOGIE UND THERAPEUTISCHE WIRKSAMKEIT (2008) (0)
- Elimination Hepatitis B Virus (HBV)-infizierter Hepatozyten durch die Induktion mitochondrialer Apoptose-Signalwege (2010) (0)
- 3.6 - Detektion von Antikörpern gegen SARS-CoV-2 und ihrem Neutralisationspotential mittels Microarray-Immunoassays (2021) (0)
- Großer Lebensmittel-assoziierter Ausbruch durch rekombinante Noroviren GII.g/GII.1 in einem süddeutschen Krankenhaus (2011) (0)
- Die antivirale Aktivität der Hämoxygenase–1 verringert die Virusproduktion in einem murinen und humanen chronischen Hepatitis-B-Modell (2005) (0)
- T cells redirected by a chimeric antigen receptor efficiently control Hepatitis B Virus replication in an immunocompetent mouse model (2014) (0)
- Abstract B63: Therapeutic potential of GPR64 specific CAR T cells in pediatric sarcomas (2017) (0)
- Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity (2021) (0)
- Hepatitis B Virus-Infected HepG2 hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8 (cid:2) T Cells In Vitro (2015) (0)
- Clinical immune monitoring: Impact of in vitro PBMC expansion on quantity and quality of HBV-specific CD4 and CD8 T cells (2015) (0)
- REDIRECTION OF T CELLS AGAINST HBV INFECTED CELLS USING SINGLE CHAIN ANTIBODY FRAGMENTS (2006) (0)
- Hepatitis B virus targets lipid transport pathways to infect hepatocytes. (2023) (0)
- 945 Central role of the hepatitis B virus X protein for the initiation of infection in primary hepatocytes (2003) (0)
- Correlation of Mutations within HDV-Protein with HLA Backgrounds of Patients Leads to Identification of Novel CD8 T Cell Epitopes (2016) (0)
- P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma (2014) (0)
- O98 T-CELL RE-DIRECTION AGAINST GLYPICAN-3 FOR IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC) (2014) (0)
- A novel non-MHC-I restricted CTL effector function mediated by TNF and XIAP (2011) (0)
- 128 INTERFERON-ALPHA ELIMINATES HBV cccDNA VIA BASE EXCISION REPAIR PATHWAY (2013) (0)
- HBV1 O‐14: Bispecific antibody constructs mediate specific retargeting towards and elimination of HBVpositive hepatocytes and tumor cells (2015) (0)
- Microneedles and Nanopatches for Transdermal Vaccination (2014) (0)
- Molecular signatures reveal a novel HLA-B(star)15-restricted CD8 T cell epitope on the large hepatitis delta antigen (2015) (0)
- Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study. (2021) (0)
- Decreased expression of microRNA-125b may contribute to the pathogenesis of hepatocellular carcinoma (2010) (0)
- Methods and compositions for the expression of heterologous genes in liver cells using vectors, which are derived from hepadnaviruses (1999) (0)
- 847 COFFEE INTERFERES WITH HCV REPLICATION IN VITRO BY INHIBITION OF WNT SIGNALING (2012) (0)
- Neighbor of Punc E11 (Nope): Ein neuer Biomarker für hepatozelluläre Karzinome der Maus (2008) (0)
- Improved HBV based vectors for a liver directed gene transfer (2003) (0)
- 56 Regulated and liver specific expression of IFN gamma allows analysis of the effect on HBV replication in mice (2004) (0)
- [Omeprazole. Its pharmacology and therapeutic efficacy]. (1993) (0)
- A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study (Preprint) (2021) (0)
- Correlation of fulminant hepatitis B and escape mutations in the 2nd loop of the HBsAg a-determinant (2014) (0)
- Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting (2020) (0)
- P.042 Studies on the control of HBV infection in a mouse model of acute hepatitis B (2006) (0)
- MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (0)
- Persistent Hepatitis B Virus Infection in the Liver Is at Risk to Develop Cirrhosis and Hepatocellular Carcinoma (2014) (0)
- Degree of hepatocytes differentiation and expression levels of liver specific transcription factors: influence of Hepatitis B Virus replication (2006) (0)
- Immunotherapeutic retargeting of effector cells towards HBV infected target cells using bispecific antibody constructs (2014) (0)
- Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection (2019) (0)
- Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles (2022) (0)
- HCV-specific immune responses under direct-acting antiviral therapy of chronic HCV infection (2015) (0)
- Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination (2021) (0)
- 636 HBV SPECIFIC IMMUNE RESPONSES IN HBV TRANSGENIC MICE CAN STRONGLY BE ENHANCED BY IMMUNIZATION WITH DENDRITIC CELLS PULSED BY HBVSVP (2010) (0)
- COVID-19 and Beyond: A Call for Action and Audacious Solidarity to All the Citizens and Nations, It Is Humanity’s Fight (2020) (0)
- 340 T CELLS REDIRECTED BY A CHIMERIC ANTIGEN RECEPTOR RECOGNIZING HBsAg EFFICIENTLY CONTROL HBV IN VIVO IN TRANSGENIC MICE (2013) (0)
- 309 GENERATION OF T CELLS DIRECTED AGAINST α-FETOPROTEIN FOR IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (2012) (0)
- Self-sampling may be a viable sample collection method for SARS‑CoV‑2 testing (2021) (0)
- Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors (2016) (0)
- Liver sinusoidal endothelial cells and Kupffer cells contribute to HCV innate immune response via TLR3 (2015) (0)
- P04.09 Development of a dendritic cell vaccine against hepatocellular carcinoma using VSV-NDV (2020) (0)
- Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study (2015) (0)
- The PRMT 1 methyltransferase is a binding partner of HBx and a negative 1 regulator of hepatitis B virus transcription 2 3 4 Running title : Functional interaction between HBx and PRMT 1 5 6 (2013) (0)
- Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages (2022) (0)
- The p53 family is involved in the elimination of Hepatitis B virus (HBV)-infected hepatocytes (2011) (0)
- Animal variants of sodium-taurocholate co-transporting polypeptide permitting hepatitis B virus infection (2022) (0)
- Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems (2019) (0)
- Real-time monitoring of HBV-infection in mice revealed antigen level depended outcome of acute and chronic liver infection (2019) (0)
- 90 FOXP3+ CD4+ REGULATORY T-CELLS MITIGATE IMMUNE RESPONSES AND TISSUE DAMAGE IN A MURINE MODEL OF ACUTE HEPATITIS B VIRUS INFECTION (2010) (0)
- Table of contents (2016) (0)
This paper list is powered by the following services:
Other Resources About Ulrike Protzer
What Schools Are Affiliated With Ulrike Protzer?
Ulrike Protzer is affiliated with the following schools:
